Does CBD really work?
UC experts join WVXU's Cincinnati Edition
As recreational marijuana sales are coming to Ohio, more CBD shops are springing up in the meantime selling a variety of tinctures, topicals and tonics with various claims of health benefits. CBD is claimed to relieve pain, anxiety, insomnia and more, but what does the research say?
The University of Cincinnati's LaTrice Montgomery, PhD, and Michael Privitera, MD, joined WVXU's Cincinnati Edition to discuss how CBD claims stack up to scientific research.
Privitera said Epidiolex, a CBD medication for epilepsy, is currently the only Food and Drug Administration approved CBD treatment. Epidiolex contains more than 10 to 20 times the CBD concentration of products that can be purchased in health food stores or gas stations.
"There’s a lot of other information out there, but...the FDA has not approved CBD for anything other than epilepsy," said Privitera, professor and division chief for epilepsy in UC's Department of Neurology and Rehabilitation Medicine in UC's College of Medicine and director of the UC Gardner Neuroscience Institute Epilepsy Center. "If you look at for example medical marijuana laws in the state of Ohio, there’s lots of conditions...But there’s not been good randomized clinical trial data about most of the indications including pain, anxiety and sleep."
Montgomery said in Ohio, hemp products are certified by the Ohio Department of Agriculture, but it is not strictly regulated. Studies have found the actual concentration of CBD in consumer products can vary widely compared to what is on its label.
"So it may suggest there’s a low level of THC in hemp products when actually there might be higher levels, and vice versa," said Montgomery, adjunct associate professor in the Department of Psychiatry and Behavioral Neuroscience in UC's College of Medicine and a licensed clinical psychologist. "So it’s not very well regulated."
Listen to the Cincinnati Edition segment.
Featured photo at top of CBD oil. Photo/CBD Infos/Unsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.